Literature DB >> 1117921

Letter: Deanol for tardive dyskinesia.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117921     DOI: 10.1056/NEJM197504242921720

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

2.  Tardive dyskinesia and psychotropic drug history.

Authors:  G M Simpson; E Varga; J H Lee; B Zoubok
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

3.  Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesia.

Authors:  K L Davis; L E Hollister; A L Vento; B A Beilstein; G R Rosekind
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

4.  [Deanol in tardive dyskinesia: a double-blind study (author's transl)].

Authors:  S Bockenheimer; G Lucius
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-09-17

5.  Deanol in the treatment of tardive dyskinesia.

Authors:  G M Simpson; A Voitashevsky; M A Young; J H Lee
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

6.  2-dimethylaminoethanol (Deanol) in Huntington's chorea.

Authors:  T A Caraceni; F Girotti; I Celano; E Parati; L Balboni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-12       Impact factor: 10.154

7.  Pharmacological characterization of tardive dyskinesia.

Authors:  D E Casey; D Denney
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

Review 8.  Cholinergic medication for antipsychotic-induced tardive dyskinesia.

Authors:  Irina Tammenmaa-Aho; Rosie Asher; Karla Soares-Weiser; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-03-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.